Research
The Science
At Revian, we are a company rooted in science, technology, and data. Please read our technical papers below to better understand our patented technology and the supporting data that brought Revian to market.
LED Therapy in Treating Androgenetic Alopecia
There are many FDA-cleared medical devices for treatment of alopecia, falling under one of two board categories: lasers or light-emitting diodes (LEDs).
Dual-wavelength LED Therapy & DHT Inhibition
Inhibition of dihydrotestosterone (DHT) formation via dual wavelength orange-red light production of nitric oxide.
Clinical Safety and Efficacy of an At-Home, Dual Wavelength Red Light Hair Growth System in Subjects with Androgenetic Alopecia
After 16 weeks, subjects that were treated with the dual wavelength red light device were at last 80% compliant.
Clinical Efficacy of an At-Home, 620 and 660 nm Red Light Treatment on Scalp Pruritus and Irritation
Eighty-one subjects were randomized to either a dual wavelength 620 nm and 660 nm light therapy device pairs with a Bluetooth-connected mobile app (REVIAN RED System) or to a sham comparator device with a similar user experience through the mobile app to track daily treatment compliance between both groups.
